In a recent study on human ovarian cancer cells it was found that DHA could reverse paclitaxel resistance by inhibiting P-gp as well as downregulating the expression of multidrug resistance associated proteins (MRP) and inhibiting the activity of NF-κB and p38 MAPK signalling pathways [161]. Here, PGP is linked to ovarian cancer.